share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

香港交易所 ·  Apr 10 05:14
Summary by Moomoo AI
無錫藥明康德於2024年3月11日至4月10日期間，進行了多次股份回購，共回購了數百萬股A股股份。根據香港聯合交易所有限公司證券上市規則，公司必須披露股份變動情況。在此期間，藥明康德的股份回購價格與市價相比，出現了折讓或溢價的情況。公司於2024年4月10日的結存為2,546,260,847股。藥明康德確認，所有回購活動均按照上海證券交易所的相關規則進行。
無錫藥明康德於2024年3月11日至4月10日期間，進行了多次股份回購，共回購了數百萬股A股股份。根據香港聯合交易所有限公司證券上市規則，公司必須披露股份變動情況。在此期間，藥明康德的股份回購價格與市價相比，出現了折讓或溢價的情況。公司於2024年4月10日的結存為2,546,260,847股。藥明康德確認，所有回購活動均按照上海證券交易所的相關規則進行。
Between March 11 and April 10, 2024, Wuxi Pharmaceutical Ming Kand has repurchased several million shares of A-shares. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in shares. During this period, there was a discount or premium on the share repurchase price of Pharma Kond compared to the market price. The company had a deposit of 2,546,260,847 shares as of April 10, 2024. YUMINGKAND CONFIRMS THAT ALL REPURCHASES ARE CARRIED OUT IN ACCORDANCE WITH THE RELEVANT RULES OF THE SHANGHAI STOCK EXCHANGE.
Between March 11 and April 10, 2024, Wuxi Pharmaceutical Ming Kand has repurchased several million shares of A-shares. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in shares. During this period, there was a discount or premium on the share repurchase price of Pharma Kond compared to the market price. The company had a deposit of 2,546,260,847 shares as of April 10, 2024. YUMINGKAND CONFIRMS THAT ALL REPURCHASES ARE CARRIED OUT IN ACCORDANCE WITH THE RELEVANT RULES OF THE SHANGHAI STOCK EXCHANGE.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more